Literature DB >> 12168079

Has lung cancer in the elderly different characteristics at presentation?

Maurizio Montella1, Cesare Gridelli, Anna Crispo, Francesco Scognamiglio, Pasquale Ruffolo, Tindaro Gatani, Vincenzo Boccia, Paolo Maione, Gabriella Fabbrocini.   

Abstract

Lung cancer is the first cause of cancer death for males aged > or =35 years, and the second for females aged between 35 and 70 years. Elderly patients seem to have the worst performance status (PS) and earlier stage of disease at diagnosis. We analyzed data concerning 1,035 patients with lung cancer referred to the National Cancer Institute of Naples. The variables considered in the analysis were: gender; type of cancer [small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC)]; ECOG (Eastern Cooperative Oncology Group) PS, the stage of disease at diagnosis, the histological type, age at diagnosis. In order to better assess the relevance of age at diagnosis in lung cancer patients we categorized the age into two groups (young < or =70; old >70 years). The statistical analyses were performed using chi2 trend test with corresponding p-value and odds ratios (OR) for the examined variables, with a corresponding 95% confidence interval. These were derived using multiple logistic regression, fitted by the maximum likelihood method. For all the 1035 patients the risk between the age at diagnosis and the performance status was not statistically significant (OR=1.1, 95%CI 0.8-1.5). We repeated the same risk distinguishing the histological type and we analyzed the performance status for the SCLC (OR=1.0, 95%CI 0.4-2.5) and the stage at diagnosis (OR=1.0, 95%CI 0.4-3.0), without any significant difference. Our study showed that elderly patients with lung cancer do not seem to have different characteristics at presentation, particularly related to stage of disease, PS and histology, as compared to their younger counterpart. Other characteristics such as type and number of co-morbidities and organ function differ in the two groups of populations.

Entities:  

Mesh:

Year:  2002        PMID: 12168079

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901.

Authors:  Riichiroh Maruyama; Noriyuki Ebi; Junji Kishimoto; Masato Kato; Tokujiro Yano; Yoshinori Nagamatsu; Shuichi Tsukamoto; Shinji Akamine; Sho Saeki; Yukito Ichinose
Journal:  Int J Clin Oncol       Date:  2013-01-26       Impact factor: 3.402

2.  Clinical features and prognostic factors in elderly koreans with advanced non-small-cell lung cancer in a tertiary referral hospital.

Authors:  Seo Woo Kim; Mi Yeon Kim; Yoon Pyo Lee; Yon Ju Ryu; Seok Jeong Lee; Jin Hwa Lee; Jung Hyun Chang; Sung Shine Shim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.